Cross-talk between the ligand- and DNA-binding domains of estrogen receptor

Proteins: Structure, Function and Bioinformatics

Volumn 81, Issue 11, 2013, Pages 1900-1909

  Huang, Wei ^a   Greene, Geoffrey L ^b   Ravikumar, Krishnakumar M ^a   Yang, Sichun ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

CG model; Energy landscape; Estrogen receptor; MD; Protein protein interaction

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; LYSINE;

ARTICLE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DNA BINDING; DNA BINDING DOMAIN; HORMONE BINDING; LIGAND BINDING; LIGAND BINDING DOMAIN; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN CROSS LINKING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

CG MODEL; ENERGY LANDSCAPE; ESTROGEN RECEPTOR; MD; PROTEIN-PROTEIN INTERACTION;

BINDING SITES; DNA; ESTROGEN RECEPTOR ALPHA; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 84885711476     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.24331     Document Type: Article

References (54)

1. Krust A, Green S, Argos P, Kumar V, Walter P, Bornert J, Chambon P. The chicken oestrogen receptor sequence: homology with v-erba and the human estrogen and glucocorticoid receptors. EMBO J 1986;5:891-897.
2. Kumar V, Green S, Staub A, Chambon P. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 1986;5:2231-2236.
3. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P. Functional domains of the human estrogen receptor. Cell 1987;51:51-941.
4. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-895.
5. Notides A, Lerner N, Hamilton D. Positive cooperativity of the estrogen receptor. Proc Natl Acad Sci USA 1981;78:4926-4930.
6. Kumar V, Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 1988;55:145-156.
7. Wang H, Peters G, Zeng X, Tang M, Ip W, Khan S. Yeast two-hybrid system demonstrates that estrogen receptor dimerization is ligand-dependent in vivo. J Biol Chem 1995;270:23322-23329.
8. Nilsson S, Mkel S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA. Mechanisms of estrogen action. Physiol Rev 2001;81:1535-1565.
9. Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, Maggi A, Muramatsu M, Parker MG, Gustafsson JA. International union of pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 2006;58:773-781.
10. Jordan VC. Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov 2003;2:205-213.
11. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple outcomes of raloxifene evaluation (more) investigators. JAMA 1999;282:637-645.
12. Osborne CK, Zhao H, Fuqua SA. Selective estrogen receptor modulators: structure, #function, and clinical use. J Clin Oncol 2000;18:3172-3186.
13. Tora L, White J, Brou C, Tasset D, Webster N, Scheer E, Chambon P. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 1989;59:477-487.
14. Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E, Ferrin T. UCSF Chimera visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605-1612.
15. Schwabe JW, Chapman L, Finch JT, Rhodes D, Neuhaus D. DNA recognition by the oestrogen receptor: from solution to the crystal. Structure 1993;1:187-204.
16. Schwabe JW, Chapman L, Finch JT, Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 1993;75:567-578.
17. Schwabe JW, Chapman L, Rhodes D. The oestrogen receptor recognizes an imperfectly palindromic response element through an alternative side-chain conformation. Structure 1995;3:201-213.
18. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrm O, Ohman L, Greene GL, Gustafsson JA, Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997;389:753-758.
19. Tanenbaum DM, Wang Y, Williams SP, Sigler PB. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci USA 1998;95:5998-6003.
20. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998;95:927-937.
21. Gangloff M, Ruff M, Eiler S, Duclaud S, Wurtz JM, Moras D. Crystal structure of a mutant hERα ligand-binding domain reveals key structural features for the mechanism of partial agonism. J Biol Chem 2001;276:15059-15065.
22. Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol 2002;9:359-364.
23. Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP, Rastinejad F. Structure of the intact PPARγ-RXRα nuclear receptor complex on DNA. Nature 2008;456:350-356.
24. Zhang J, Chalmers MJ, Stayrook KR, Burris LL, Wang Y, Busby SA, Pascal BD, Garcia-Ordonez RD, Bruning JB, Istrate MA, Kojetin DJ, Dodge JA, Burris TP, Griffin PR. DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat Struct Mol Biol 2011;18:556-563.
25. Helsen C, Dubois V, Verfaillie A, Young J, Trekels M, Vancraenenbroeck R, De Maeyer M, Claessens F. Evidence for DNA-binding domain-ligand-binding domain communications in the androgen receptor. Mol Cell Biol 2012;32:3033-3043.
26. Fiser A, Do R, Šali A. Modeling of loops in protein structures. Protein Sci 2000;9:1753-1773.
27. Ravikumar K, Huang W, Yang S. Coarse-grained simulations of protein-protein association: an energy landscape perspective. Biophys J 2012;103:837-845.
28. Yang S, Onuchic JN, Levine H. Effective stochastic dynamics on a protein folding energy landscape. J Chem Phys 2006;125:054910.
29. Sobolev V, Sorokine A, Prilusky J, Abola E, Edelman M. Automated analysis of interatomic contacts in proteins. Bioinformatics 1999;15:327-332.
30. Kim YC. Hummer G. Coarse-grained models for simulations of multiprotein complexes: application to ubiquitin binding. J Mol Biol 2008;375:1416-1433.
31. Miyazawa S. Jernigan RL. Residue-residue potentials with a favorable contact pair term and an unfavorable high packing density term, for simulation and threading. J Mol Biol 1996;256:623-644.
32. Brooks BR, Brooks C, III, Mackerell A, Jr, Nilsson L, Petrella RJ, Roux B, Won Y, Archontis G, Bartels C, Boresch S, Caflisch A, Caves L, Cui Q, Dinner AR, Feig M, Fischer S, Gao J, Hodoscek M, Im W, Kuczera K, Lazaridis T, Ma J, Ovchinnikov V, Paci E, Pastor RW, Post CB, Pu JZ, Schaefer M, Tidor B, Venable RM, Woodcock HL, Wu X, Yang W, York DM, Karplus M. CHARMM: the biomolecular simulation program. J Comput Chem 2009;30:1545-1614.
33. Yang S, Roux B. Src kinase conformational activation: thermodynamics, pathways, and mechanisms. PLoS Comput Biol 2008;4:e1000047.
34. Schlitter J, Engels M, Krger P. Targeted molecular dynamics: a new approach for searching pathways of conformational transitions. J Mol Graph 1994;12:84-89.
35. Tsui V, Case DA. Theory and applications of the generalized born solvation model in macromolecular simulations. Biopolymers 2000;56:275-291.
36. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K. Scalable molecular dynamics with namd. J Comput Chem 2005;26:1781-1802.
37. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C. Comparison of multiple amber force fields and development of improved protein backbone parameters. Proteins 2006;65:712-725.
38. Pérez A, Marchán I, Svozil D, Sponer J, Cheatham TE, III, Laughton CA, Orozco M. Refinement of the AMBER force field for nucleic acids: improving the description of α/γ conformers. Biophys J 2007;92:3817-3829.
39. Aaqvist J. Ion-water interaction potentials derived from free energy perturbation simulations. J Phys Chem 1990;94:8021-8024.
40. Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J Comput Chem 2004;25:1157-1174.
41. Wang J, Wang W, Kollman PA, Case DA. Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 2006;25:247-260.
42. Jakalian A, Bush BL, Jack DB, Bayly CI. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. method. J Comput Chem 2000;21:132-146.
43. Jakalian A, Jack DB, Bayly CI. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. parameterization and validation. J Comput Chem 2002;23:1623-1641.
44. Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods RJ. The Amber biomolecular simulation programs. J Comput Chem 2005;26:1688-1668.
45. Paige LA, Christensen DJ, Grn H, Norris JD, Gottlin EB, Padilla KM, Chang, CY, Ballas LM, Hamilton PT, McDonnell DP, Fowlkes DM. Estrogen receptor (ER) modulators each induce distinct conformational changes in er alpha and er beta. Proc Natl Acad Sci USA 1999;96:3999-4004.
46. Kong EH, Heldring N, Gustafsson JA, Treuter E, Hubbard RE, Pike ACW. Delineation of a unique protein-protein interaction site on the surface of the estrogen receptor. Proc Natl Acad Sci USA 2005;102:3593-3598.
47. Wang Y, Chirgadze N, Briggs S, Khan S, Jensen E, Burris T. A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor β. Proc Natl Acad Sci USA 2006;103:9908-9911.
48. Chandra V, Huang P, Potluri N, Wu D, Kim Y, Rastinejad F. Multidomain integration in the structure of the HNF-4α nuclear receptor complex. Nature 2013;495:394-398.
49. Kuntz M, Shapiro D. Dimerizing the estrogen receptor DNA binding domain enhances binding to estrogen response elements. J Biol Chem 1997;272:27949-27956.
50. Levitt M. Nature of the protein universe. Proc Natl Acad Sci USA 2009;106:11079-11084.
51. Zheng W, Schafer NP, Davtyan A, Papoian GA, Wolynes PG. Predictive energy landscapes for protein-protein association. Proc Natl Acad Sci USA 2012;109:19244-19249.
52. Tompa P. On the supertertiary structure of proteins. Nat Chem Biol 2012;8:597-600.
53. Rochel N, Ciesielski F, Godet J, Moman E, Roessle M, Peluso-Iltis C, Moulin M, Haertlein M, Callow P, Mely Y, Svergun DI, Moras D. Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings. Nat Struct Mol Biol 2011;18:564-570.
54. Orlov I, Rochel N, Moras D, Klaholz BP. Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA. EMBO J 2012;31:291-300.